ChineseInvestors.com, Inc. (CIIX)

Our latest clients all have the potential to grow significantly in the near and long-term future

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Mon Sep 11, 2017 4:29 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Retains Biopsy, LLC to Provide Leadership in Growth and E-Commerce

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its retention of Biopsy, LLC, managed by bestselling author Chris J. Snook, to provide leadership in growth and e-commerce. Effective September 1, 2017, Biopsy, LLC will serve as the architect of the digital infrastructure and go-to-market strategy for ChineseInvestors.com, Inc. and its subsidiaries, reporting directly to the companies’ management teams. “ChineseInvestors.com, Inc. is fortunate to be able to contract with Biopsy, LLC as Chris’ unique skill and experience will enhance the Company’s ability to effectively emerge as a leader in the CBD Biotechnology Industry, while also strengthening and expanding the market reach and value of the Company’s core financial media business,” Warren Wang, CEO and founder of CIIX, stated in the news release. “Online purchases by Chinese consumers now exceed that of US consumers and global online sales are expected to grow 20% annually. ChineseInvestors.com, Inc. is committed to building the necessary platforms to capitalize on this growth trend and to emerge as a market leader.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Tue Sep 12, 2017 4:22 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Records 76% YOY Increase in Revenues for FY2017

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its financial results for the fiscal year ended May 31, 2017. Among the highlights, the company recorded a 76 percent increase in total operating revenues as compared to 2016. CIIX noted that both its investor relations business and its subscription business posted strong growth during the 12-month period, with revenues increasing by 130 percent and 57 percent, respectively. The company also provided an update on its outlook for fiscal year 2018. “Although the business of our Consumer Division is still in the early stages, the recently launched ‘OptHemp’ product line is gaining popularity among Chinese consumers in the US, and the Company’s first hemp-infused skin care product line will launch in China in the coming months,” Warren Wang, founder and CEO of CIIX, stated in the news release. “We believe that through the efforts of our business strategists … we will generate substantial revenues in FY 2018 via sales of our hemp-based products in the United States and China. Our overall goal in 2018 is for the Company is to achieve annual revenue growth of more than 100%, while cutting costs and achieving profitability.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Thu Sep 14, 2017 5:03 pm

Innovative Cannabis Players Offer Promising Entry into Explosive Market

NetworkNewsWire Editorial Coverage: It is no secret that the legal marijuana market is exploding in North America. Analysts have predicted the cannabis market in the United States could reach $24.1 billion by 2025, and recent polls indicate 61 percent of Americans now believe marijuana use should be federally legalized1. Measures are currently being taken in Canada to legalize recreational marijuana by 2018. On a global scale, the worldwide cannabis market has been projected to reach up to $55.8 billion USD by 20252. A wide variety of players have been scrambling to stake a claim in this booming market, whether through directly handling the marijuana plant or by serving those who do. Unique standouts in this burgeoning market include ChineseInvestors.com, Inc. (CIIX) (CIIX Profile), CV Sciences, Inc. (CVSI), Terra Tech Corp. (TRTC), Medical Marijuana, Inc. (MJNA) and Hemp, Inc. (HEMP).

ChineseInvestors.com, Inc. (CIIX) is tapping into a profitable niche market as it serves Chinese-speaking consumers throughout the world and aims to become the largest publicly traded Chinese medical marijuana company.

CIIX is focused on the research, development and distribution of legalized cannabidiol (CBD) to the global Chinese-speaking community. Already one of the fastest growing segments in the U.S. hemp and legal marijuana industry, application of CBD is also gaining traction in China. CIIX operates an online store in the free trade zone of Shanghai, China, where CBD sales are legal, though marijuana use is not. CIIX also recently established, through its wholly owned subsidiary ChineseHempOil.com, Inc., a club-style Hemp Education Center in the company’s home market of San Gabriel, California, to educate interested parties regarding the potential health benefits of non-industrial hemp and hemp-derived CBD (http://nnw.fm/oV4Ga).

CIIX recently engaged Arizona-based Launch Haus LLC, a holding company that specializes in digital direct-to-consumer marketing and product branding, to aid in growing the company’s worldwide sales of hemp-based CBD products (http://nnw.fm/RVz21). In June 2017, the company further incorporated CBD Biotechnology Inc. in British Columbia, Canada, as part of its efforts to enter the medical marijuana market there. Medical marijuana has been federally legal in Canada since 2001, and the Canadian government is now making strides toward the national legalization of recreational marijuana.

“The incorporation of CBD Biotechnology Inc. is a promising step forward toward CIIX’s goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims to generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health,” Warren Wang, founder and CEO of CIIX, stated in a news release (http://nnw.fm/9y0Dc).

In December 2016, CIIX entered into a wholesale agreement with a well-known CBD health brand and formally launched a website for its subsidiary, ChineseCBDoil.com, which went live in January 2017. This launch marked the introduction of the world’s first Chinese language online store for CBD health products. At that same time, CIIX debuted the first Chinese language Yelp-style social media app where users can discuss and review cannabis services and products, as well as find locations of dispensaries.

The company has built a widespread user base of more than 100,000 individuals, and it continues its focus on investing in both the R&D and distribution of CBD products. Corporate objectives include plans to further its study into the effectiveness of CBD for medicinal purposes in an effort to become the first company in China to employ CBD oil as a means of mitigating the suffering of epilepsy and Alzheimer’s patients. The application period for such new drugs in China is only two to four years—significantly shorter than the time it often takes companies to fulfill regulatory requirements in the United States.

As CIIX continues to penetrate new markets, others are taking notice. Consilium Global Research recently projected a CAGR of almost 100 percent for CIIX through 2026 (http://nnw.fm/e5EiK), predicting revenues of up to $14.8 million.

Another standout cannabis player is CV Sciences, Inc. (CVSI), which operates two distinct divisions: pharmaceuticals and consumer products. The company’s pharmaceuticals division is focused on the development and commercialization of novel therapeutics that utilize synthetic CBD. Its consumer products division manufactures, markets and sells plant-based CBD products to various market sectors, distributing these products nationally through the Internet as well as through health food stores and health care provider offices. The company’s divisions are backed by a medical and scientific advisory board, as well as state-of-the-art production facilities, and its consumer products are supported by formal safety reviews, increasing case reports and recommendations from physicians. CV Sciences is pursuing FDA approval for drugs with particular indications, featuring CBD as the active pharmaceutical ingredient, and the company has achieved promising preclinical results. CV Sciences’ initial drug candidate is CVSI-007, a chewing gum that contains nicotine and synthetic CBD to aid individuals in quitting tobacco use and escaping addiction.

Vertically integrated, cannabis-focused agricultural company Terra Tech Corp. (TRTC) is another interesting marijuana play, operating through various subsidiaries including Blüm, IVXX Inc., Edible Garden and MediFarm LLC. Three of these subsidiaries are cannabis-focused. Blüm operates retail and medical cannabis facilities that deliver high-quality medical marijuana products to patients seeking alternative treatments for chronic medical conditions, as well as premium cannabis for Nevada’s adult-use market. IVXX, Inc. produces cannabis-extracted products for regulated medical marijuana dispensaries throughout California and adult-use and medical cannabis dispensaries in Nevada. Under the IVXX brand, Terra Tech recently filed a patent with the U.S. Patent and Trademark Office for cannabis-infused rolling papers, which are anticipated to be released in 2018. The company’s MediFarm LLC subsidiaries are focused on medical and adult-use cultivation and permitting businesses in Nevada.

Medical Marijuana, Inc. (MJNA) stood out as the first company to offer hemp-based CBD products in the United States. The company accomplished this by offering cannabis-derived products that exploit the health properties of non-psychoactive cannabinoids, like CBD, which are legal in the U.S. The company uses cannabis varieties (hemp) that are grown outside the U.S. and either have very low tetrahydrocannabinol levels or no THC at all. Carefully cultivated CBD hemp oil and hemp oil products, offering a full range of phytocannabinoids and high CBD content, are created and then imported into the U.S. In addition to being the first publicly traded cannabis company in the U.S., MJNA has stood out as the first company to bring legal medical cannabis products to Mexico, Brazil, Puerto Rico and Paraguay; the first company to offer government-subsidized botanical cannabis-based products; the first company to deliver prescription CBD products to treat epilepsy, Alzheimer’s, Parkinson’s, chronic pain and migraine; the first company to deliver cannabis brands across U.S. state lines and international borders; and more.

Hemp, Inc. (HEMP) is an industrial hemp-focused company that aims to become a leader in the industrial hemp market through a portfolio of synergistic businesses formed through purchase, acquisition or joint venture with companies across various hemp industry sectors. Hemp, Inc.’s mission is to offer green solutions through its hemp products, which are eco-friendly and can often be used in place of petroleum-based products. The American hemp fiber industry has been estimated at over $500 million, and a hemp crop is known to be more economical and ecological than cotton or trees, reducing water, energy and pesticide use. Hemp, Inc.’s products include DrillWall lost circulation material for oil field drilling application and Spill-Be-Gone and SpillSuck for large- and small-scale oil spill cleanup. The company is also developing SpillMaster for offshore oil spill cleanup.

For investors seeking play in the cannabis market, the mentioned companies offer intriguing and varied opportunities. As this burgeoning market continues its forward drive, these companies may provide promising opportunities to climb aboard.

Editorial Sources:
1) CBS News: http://nnw.fm/5Qh2x
2) Grand View Research: http://nnw.fm/Gf3dQ

For more on CIIX please visit: ChineseInvestors.com (CIIX) or www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Fri Sep 15, 2017 3:39 pm

ChineseInvestors.com, Inc. (CIIX) Sets Goal of Greater than 100% Gain in FY2018 Revenues

- In FY2017, the company’s investor relations business grew 130%, and its subscriptions business rose by 57%
- Warren Wang, founder and chief executive officer of CIIX, sets goal of greater than 100% gain in sales in FY2018 and cost-cutting to achieve profitability
- Company excited about its expansion of auxiliary services into the digital currency industry; Wang says that market will offer long-term opportunities

ChineseInvestors.com, Inc. (OTCQB: CIIX) recorded a skyrocketing 76% year-over-year operating revenues increase for its fiscal year ended May 31, 2017. The company’s two divisions exhibited double-digit and triple-digit growth in FY2017. The investor relations business grew 130%, while the subscriptions business rose 57% during the 2017 fiscal year, the company reported (http://nnw.fm/UF4Gn). Total sales grew to $1,667,977 in FY2017 compared to $948,385 the prior year.

Warren Wang, founder and chief executive officer of CIIX, says the company’s goal is more than a 100% jump in FY2018 sales, while cutting costs and achieving profitability.

The primary reason for the increase in sales for the two divisions was a decision by management to be more discerning in deciding which companies would receive its investor relations services. Also, the firm placed itself on a more cash compensation basis — resulting in more sales — rather than taking equity compensation.

CIIX has a goal of becoming the primary Chinese medical cannabis publicly traded company. It is focused on the R&D and distribution of legalized, hemp-based cannabidiol (CBD) to the global Chinese-speaking community. It maintains an online store in the free trade zone of Shanghai, China, and plans on opening a brick-and-mortar outlet in San Gabriel, California.

Before the end of 2017, CIIX plans to launch a cryptocurrency education and trading subscription service and the first Chinese daily video news broadcast from the NYSE covering digital currency and blockchain technology. It has also established CBD Biotechnology Co., Ltd., as a wholly-owned subsidiary in Shanghai, China. It launched OptHemp, its first hemp oil product line. In the coming months, the company said, it will unveil in China its first hemp-infused skin care product line.

“I am very pleased about the Company’s significant increase in revenue in the fiscal year ended May 31, 2017,” Warren Wang, founder and chief executive officer of CIIX, stated in a news release. “Although the blueprint of our Company’s business strategy has expanded through its entrance into the Hemp Industry, our core subscription and investors relations services remain strong with significant growth rates. I am thankful for the investors who have supported our ongoing development plans and look forward to a prosperous year ahead.”

For its non-industrial hemp-based products, the company has engaged Scottsdale, Arizona-based Launch Haus LLC to help it in its direct response marketing, digital, e-commerce and direct sales channels.

In addition, the company has thus far realized $2 million through August 29, 2017, from its private placement of some 10 million shares of its Series D-2017 convertible preferred stock, priced at $1 per share.

For more information, visit the company’s website at www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Mon Sep 18, 2017 4:09 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Subsidiary Completes China FDA Filing; Moves toward Launch of Hemp-Infused Skin Care Line

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary CBD Biotechnology Co. Ltd., this morning announced that it has completed the record filing process with the China Food & Drug Administration (“CFDA”) for its first line of non-industrial hemp-infused skin care products. Following this milestone, the company expects to launch its ‘CBD Magic Hemp Series’ skin care line in the next couple of months, effectively positioning CBD Biotechnology as a leader in what the company has called “an untapped segment of China’s skin care industry.” “I am very pleased to announce the upcoming launch of CBD Biotechnology’s non-industrial hemp-infused skin care line, CBD Magic Hemp Series,” Summer Yun, CEO of CBD Biotechnology, stated in the news release. “We have not only completed the filing process with CFDA, but we have also contracted with a large processing factory in Shanghai, China, with over 14-years of experience in cosmetics production.” Upon launch, the initial CBD Magic Hemp Series product line is expected to include a brightening and refreshing moisturizer, a perfecting shield primer and a peptide collagen solution.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Wed Sep 20, 2017 3:54 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Director Featured in SmallCapVoice Interview

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its director of investor relations, Alan Klitenic, was featured in a recent interview with SmallCapVoice.com. In the interview, which can be heard at http://nnw.fm/flQB8, Klitenic discusses CIIX’s recent news, including updates related to the digital currency industry, the company’s plans to launch a Chinese daily video news broadcast from the NYSE floor, CIIX’s recent financial performance and its completion of the record filing process with the Chinese FDA related to its soon-to-be-launched hemp infused skin care line. “I want to emphatically state that CIIX is ready to make sales in China,” Klitenic stated during the interview. “We have successfully passed through the regulatory body, the China FDA. We have manufactured this product: CBD Infused skin care products line with a design patent. This is a real milestone for us at ChineseInvestors.com. We are going to spend money and promote our CBD Hemp Oil and CBD infused skin care products in China going forward from now and through 2018.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Thu Sep 21, 2017 6:18 pm

Cannabinoid Consumer Market Booming as CBD Enjoys Growth in Public Sentiment

NetworkNewsWire Editorial Coverage: Medical cannabis sales are set to impress even the most timid investor, with projected sales of nearly $5 billion in 2017, or about 67% of the $7.2 billion legal cannabis market. Hemp-derived cannabidiol (CBD) product sales are also expected to be a billion-dollar business within three years, growing at a projected 55% compound annual growth rate from 2016’s $170 million in revenue, according to an article in Forbes(1). As the cannabis industry continues to flourish, many publicly traded companies are finding ample opportunities to thrive. Standout companies determined to grow with the industry include ChineseInvestors.com (CIIX) (CIIX Profile), CV Sciences, Inc. (CVSI), Terra Tech Corp. (TRTC), Medical Marijuana, Inc. (MJNA) and Hemp, Inc. (HEMP)

It’s worthwhile to note that significant changes in the acceptance of medical and recreational marijuana also includes the alternative forms of CBD-infused and hemp-derived products, which most people now understand do not contain THC, the psychoactive compound found in marijuana. A massive amount of research into the health benefits of CBD and its effect on mental health disorders is also underway in the scientific community.

Branching out into the unique adaptations of the hemp oil business made perfect business sense for ChineseInvestors.com (CIIX) (www.ChineseInvestors.com), a leading financial information website for Chinese-speaking consumers and investors. CIIX has already established two wholly-owned subsidiaries based in China and the United States. CBD Biotechnology Co., Ltd., located in the free trade zone of Shanghai, China, has plans to deliver a hemp-infused skin care line in China before the end of 2017, while ChineseHempOil.com, Inc., located in the U.S., has launched its first hemp oil product line, “OptHemp.” Customers of ChineseHempOil.com can also purchase the company’s hemp-based products, foods and beverages using bitcoin (http://nnw.fm/w3pbB). The company’s annual financial results, released Tuesday, show a 76% YoY increase in revenues along with an array of new business ventures successfully being introduced to investors.

Among its offerings is the first marijuana social media mobile app designed for Chinese-speaking customers worldwide with a beta version slated for release in November. Its direct-to-consumer e-commerce business is projecting a compound annual growth rate (CAGR) of nearly 100% through FY2020, with revenues reaching $14.8 million. CIIX is positioning itself as a global leader with a goal of becoming the largest Chinese publicly traded company in the legalized CBD market targeting the world’s Chinese-speaking communities (http://nnw.fm/yA6bN).

Another company seeking to make a difference in the rapidly expanding CBD marketplace of cannabis-related products is CV Sciences, Inc. (CVSI), a preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil. The company plans to exhibit its PlusCBD Oil ™ product brand at the Natural Products Expo East September 14-16 in Baltimore, Maryland. The trade show brings together over 28,000 industry professionals and 1,400 exhibitors. CV Sciences’ product brand is sold at approximately 1,300 health food stores and continues to grow its shelf presence in various retail outlets across the county. In a news release, company spokesman Stuart Tomc said, “It’s evident that hemp-derived CBD products are doing better and growing faster than almost every other category in the supplement industry (http://nnw.fm/H2kId).”

Terra Tech Corp. (TRTC), a vertically integrated, cannabis-focused agriculture company, is also expanding its retail operations. Terra Tech Corp. operates multiple dispensaries as well as cultivation and extraction facilities in California and Nevada. Terra Tech CEO Derek Peterson said the company’s recent acquisition of Tech Center Drive Management LLC, which operates The Reserve OC medical cannabis dispensary in Santa Ana, California, represents another milestone.

“California has emerged as one of the United States’ leading legal cannabis markets, with adult-use planned to come online in 2018,” Peterson said in a news release. “Terra Tech will continue to identify opportunities to expand both its retail and cultivation capabilities in these core markets to drive forward our growth strategy and build value for shareholders (http://cnw.fm/h42vC).”

Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced that August 2017 was the company’s largest revenue month in its history. Its wholly owned subsidiaries Kannaway® and HempMeds® Mexico also experienced the best revenue month in their respective histories, Kannaway CEO Blake Schroeder said in a news release (http://cnw.fm/Evae6), noting the company’s plans to launch a series of new products in Q4 2017 as it gears up for its regional convention in Denver, Colorado, this fall. Expansion plans for entering the European market are expected to contribute to the company’s explosive growth, Schroeder added.

Making significant progress in its bid to be known as the world’s number one industrial hemp producer and exporter, HEMP, Inc. (HEMP) has appointed Dr. Robert Ian Bruck, director and founder of the North Carolina State University Environmental Technology Program, as Dean of Hemp, Inc.’s Hemp University. Bruck, who holds two doctorates and years of experience in the fields of plant pathology and ecology, will be responsible for the management and development of curriculum at The Hemp University. Educating not only the public but public policy makers about the business and scientific aspects of industrial hemp – from how to grow it to the many complexities of CBD – is a critical element of moving the cannabis industry forward., according to a company news release (http://cnw.fm/p1hbY).

While the demand for hemp-based cannabidiol has skyrocketed, so have the number of companies jumping into the market, Marijuana Business Daily reports (http://nnw.fm/7ENhH). There are now hundreds, if not thousands of hemp CBD companies flooding the market looking to take advantage of the profits to be made in the global cannabis industry. For companies like ChineseInvestors.com, which has been in business since 1999, capitalizing on the convergence of CBD and the nutrition and health products market in mainland China was a no-brainer.

In a news release (http://nnw.fm/OpHR2), Keevin Gillespie, newly appointed acting president of the company’s ChineseHempOil.com subsidiary, expressed his enthusiasm for the company’s future.

“As the many potential health benefits of hemp continue to be revealed through scientific research and development, I believe the Chinese community will embrace this rediscovered ancient remedy,” Gillespie stated. “I look forward to creating brand awareness and exposure for the Company’s ‘OptHemp’ product line, developing the Company’s network marketing division and generating significant new revenue streams for the Company in the coming year.”

Editorial Sources:
1) Forbes http://nnw.fm/rv2xH

For more on CIIX please visit: ChineseInvestors.com (CIIX) or www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Fri Sep 22, 2017 4:29 pm

For ChineseInvestors.com, Inc. (CIIX) Beauty is more than Just Skin Deep

- Entering largely untapped Chinese CBD skin care market
- Health benefits widely recognized
- Vibrant online marketing campaigns underway

Chinese women, it will be no surprise to learn, are as beauty conscious as their sisters in other countries. For centuries, they have employed a variety of cosmetic embellishments to enhance social status and, perhaps, catch someone’s eye. Lip coloring has been in vogue for at least 1,000 years, and, at some point, the application of powdered rice to lighten skin tone became fashionable. But beauty is more than skin deep, which is perhaps why ChineseInvestors.com, Inc. (OTCQB: CIIX) is launching a line of hemp-infused skin care products in China. The cannabinoid content of the line makes these products more than just cosmetics. The health virtues of cannabinoids are now widely accepted.

It’s not always that you’re known by the company you keep. Cannabidiol (CBD), the main active ingredient in CIIX’s new product line up, is, like THC, derived from cannabis sativa, but unlike its notorious associate, it is not psychotropic. Increasingly, it is being recognized to have therapeutic potential. Indeed, at a United States Senate Caucus, pre-clinical research (including both cell culture and animal models) into CBD was said to have shown ‘a range of effects that may be therapeutically useful, including anti-seizure, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-tumor, anti-psychotic, and anti-anxiety properties’ (http://nnw.fm/L4W6i). There are already products, like Sativex, that contain CBD, however, there are few directed to skincare, either in the West or in China. As such, this offers CIIX a lucrative opportunity to be a first mover in this space (http://nnw.fm/XV2Bk).

It’s an opportunity the company has embraced vigorously. CIIX recently announced that that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., had completed the record filing process with the China Food & Drug Administration (CFDA) for its first line of non-industrial hemp-infused skin care products (http://nnw.fm/Jml1B). CIIX expects to launch the ‘CBD Magic Hemp Series’ skin care line before the end of the year. The initial ‘CBD Magic Hemp Series’ launch will include:

- The CBD BIOTECH Brightening and Refreshing Moisturizer – intended to balance the skin’s moisture while forming a protective, moisturizing layer
- The CBD BIOTECH Perfecting Shield Primer – intended to even skin tone while covering fine lines and minimizing the look of pores; and
- The CBD BIOTECH Peptide Collagen Solution – intended to moisturize and firm the skin while smoothing fine lines and reducing signs of aging.

CIIX targets mainly Chinese-speaking consumers and operates an online store in the free trade zone of Shanghai, China. The company also recently established, through its wholly owned subsidiary ChineseHempOil.com, Inc., a club-style Hemp Education Center in San Gabriel, California, where it is based, to educate interested parties regarding the potential health benefits of non-industrial hemp and hemp-derived CBD. CIIX also engaged Arizona-based Launch Haus LLC, a specialist in digital direct-to-consumer marketing and product branding, to assist in growing the company’s worldwide sales of hemp-based CBD products.

Moreover in June 2017, CIIX incorporated CBD Biotechnology Inc. in British Columbia, Canada, as part of its efforts to enter the medical marijuana market there. CIIX also plans to launch a Chinese language Yelp-style mobile app for locating dispensaries and discussing cannabis products in the US.

For more information, visit the company’s website at www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Tue Sep 26, 2017 5:33 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Return of Paul Dickman as CFO

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has appointed Paul Dickman as its chief financial officer, effective September 26, 2017. Dickman previously served as the company’s CFO from July 2010 through October 2016, when he resigned in order to pursue a new opportunity. In his new position, Dickman will be responsible for leading financial operations and activities for ChineseInvestors.com, as well as establishing and monitoring its financial plan and strategies. “We are incredibly fortunate that Paul has agreed to return as our Chief Financial Officer,” Warren Wang, CEO of CIIX, stated in the news release. “We look forward to his contributions in the financial and contractual management of the Company’s growth… I am confident that Paul will serve effectively as our CFO just as he did in the past, helping us to build an infrastructure that supports long-term growth.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Thu Sep 28, 2017 4:06 pm

Cannabis Companies Demonstrate the Diverse Nature of the Global Marijuana Market

NetworkNewsWire Editorial Coverage: The cannabidiol market is large and diverse; just a few years ago, it was rather small but by 2015, consumer sales had reached $202 million, according to the CBD Report published by The Hemp Business Journal. Cannabidiol sales are expected to grow to over $2 billion by 2020. The dollar amounts and projections may seem impressive, but they don’t tell the full story, as market demand is being fueled by an increasing number of applications. Medicinal marijuana is used to treat pain and inflammation, nausea, anxiety and diseases such as epilepsy and glaucoma. The medical community has also explored its cardiovascular health benefits and potential to reduce the incidence of diabetes, help people with Alzheimer’s disease and treat cancer. ChineseInvestors.com, Inc. (CIIX) (CIIX Profile) has added cannabis-based skincare products to the mix, as well as a Yelp-style app where products can be reviewed and discussed. It’s joined in the space by companies such as CV Sciences, Inc. (CVSI), Medical Marijuana, Inc. (MJNA), Terra Tech Corp. (TRTC) and MassRoots, Inc. (MSRT).

ChineseInvestors.com, Inc. (CIIX) is staking its position in the market with several product lines, including hemp-infused skin care products. Cannabis is known to have anti-inflammatory and antioxidant properties. The company noted the benefits in this area in an August 2017 press release (http://nnw.fm/z9WPp). They include improvements to skin complexion, thanks to the omega-3 and omega-6 fatty acids present in hemp seed oil. The fatty acids help keep skin moist and stimulate collagen production, helping skin to become firmer. In fact, the human endocannabinoid system includes cannabinoid receptors in the skin.

A recent press release (http://nnw.fm/Tb3Bi) highlights the scope of the company’s hemp-infused product line. CIIX’s wholly owned enterprise, CBD Biotechnology Co. Ltd., has completed the record filing process with the China FDA for the CBD Magic Hemp Series, a line of skin moisturizer, primer and peptide collagen solutions. These cannabidiol-infused products employ the antioxidant and anti-inflammatory benefits of CBD. The ability to sell these products is good news for investors.

Alan Klitenic, Director of Investor Relations for CIIX, was recently featured in an interview with SmallCapVoice.com (http://nnw.fm/flQB8) to discuss CIIX’s hemp-infused skin care line, as well as other company achievements.

“…We have manufactured this product: CBD Infused skin care products line with a design patent. This is a real milestone for us at ChineseInvestors.com. We are going to spend money and promote our CBD Hemp Oil and CBD infused skin care products in China going forward from now and thru 2018.” He also noted that the company is ready to start building distribution channels and begin retail sales, online commerce, social media, and direct marketing initiatives to maximize revenue and the value for shareholders.

Fully aware of the demand for medical cannabis, CIIX has worked to improve the user experience as well. It has developed an investing process, known as the ChineseInvestors Method, and introduced various web-based tools to disseminate market information to investors. That puts investors on the front lines of China’s $30 billion per year skin care product industry.

The company also developed and launched a Chinese-language social media app, approved for download via the Apple App Store. It enables users to view, discuss, and write reviews on cannabis strains and marijuana dispensaries. People can use the application’s maps to find retailers, view business summary reports and see product recommendations. Social media isn’t CIIX’s only strategy, as a recent partnership with the digital agency Launch Haus LLC has spawned a marketing campaign aimed at expanding CIIX’s direct-to-consumer e-commerce business. It also appointed Keevin Gillespie as acting president of ChineseHelpOil.com, Inc., a wholly-owned subsidiary of CIIX, to brand and promote the OptHemp health product line.

As active as the company has been in the cannabis space, it is not the only mover in a fast-growing and diversifying market.

Another company with a diverse product line is CV Sciences (CVSI). Its pipeline consists of CVSI-007, a smokeless tobacco cessation product. The drug candidate comes in the form of a chewing gum, which contains nicotine and synthetic CBD. Consumer products already on the market include PlusCBD Oil, a dietary supplement sold in capsules, sprays, balms, drops, concentrates and vape liquid in nearly 1,000 retail locations. Vape blends are sold via CVSI’s Purified Liquids store, while cannabinoids are sold wholesale to serve the growing CBD wellness market. The company recently presented at the Natural Products Expo East 2017, in Baltimore, Maryland, and the MJAC2017 InvestorsHub International Cannabis Conference in Los Angeles, California.

The international cannabis market is also experiencing considerable growth, and Medical Marijuana (MJNA) distinguishes itself as the first publicly traded cannabis company in the U.S. and the first to introduce legal medical cannabis in Brazil. Its e-commerce store sells numerous brands and categories of CBD oil, including capsules, isolates, chewing gum, vape oil, vaporizer pens and body lotions and creams. In addition to pen-type vaporizers, the company also sells portable and tabletop units, as well as an electric dabbing system for vaporizing medical concentrates. All products are sold as dietary supplements rather than medical marijuana, so they can be purchased legally without doctor recommendations.

Terra Tech (TRTC) supplies the medical cannabis market via brands such as IVXX™, a cultivator and producer of different concentrates and other products, and Edible Garden®, which uses Dutch hydroponic farming methods to produce Global Food Safety Initiative-certified products, including a wide range of herbs and leafy greens. The company therefore serves the food industry as well, but it also specializes in high-grade medical cannabis that is produced at its Blüm™ facility. In addition, Terra Tech’s MediFarm division manages the permit application and procurement process for marijuana cultivators, while GrowOp Technology designs and manufactures horticultural equipment and automation/control software.

MassRoots (MSRT) offers an extremely diverse product line via its online catalog. Searchable by plant type, flavors, effects, health conditions, and manufacturer, it gives customers one of the most simple and comprehensive sources of edibles, lotions, drops and more. The company’s website has an educational article section plus a news page with frequent updates. Another resource featured on the site is a local dispensary search function, but the company also serves other businesses, providing a connection with point-of-sale systems that enable retailers to display their inventory in real time and provide customers with simple online ordering.

Cannabis companies are serving a fast-growing and diversifying market by various means. The skincare and healthcare products and social app from ChineseInvestors.com, Inc. (CIIX) are prime examples. The products and services of the companies discussed above have become relevant in the current business climate and show potential to keep pace with broader industry growth.

For more on ChineseInvestors.com please visit: ChineseInvestors.com, Inc. (CIIX)
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Thu Sep 28, 2017 4:14 pm

ChineseInvestors.com, Inc. (CIIX) Again Names Paul Dickman as CFO, Pursues Exploding $7.2 Billion Legal Cannabis Market

- CIIX is pursuing the $7.2 billion legal cannabis market with hemp-based cannabidiol (CBD) products; CIIX showed a 76% year-over-year operating revenues gain in FY2017
- Dickman previously served as CFO from 2010-2016; Warren Wang, CIIX’s CEO, said Dickman will “build an infrastructure that supports long-term growth”
- CIIX has plans to launch a hemp-based line of skin care products in China by year-end 2017 and is already marketing a line of hemp-infused cannabidiol products, “OptHemp,” through its U.S. subsidiary

ChineseInvestors.com, Inc. (OTCQB: CIIX) announced in an 8K SEC filing (http://nnw.fm/UA4wB) that Paul Dickman has returned as its chief financial officer, effective September 25, 2017. He served earlier as CFO of the company from July 2010 through October 2016. In his new position, he remains on the company’s board of directors and, as CFO, will now also be responsible for leading CIIX’s financial operations as well as instituting the company’s financial plan and strategies.

CIIX is aggressively pursuing the $7.2 billion legal cannabis market (http://nnw.fm/S17sa) with hemp-based cannabidiol (CBD) products targeted at the global Chinese-speaking community. By the end of 2017, it plans to market a hemp-infused skin care line in China through its CBD Biotechnology Co., Ltd. subsidiary. It is already marketing its OptHemp line of hemp oil-based products through its U.S. subsidiary, ChineseHempOil.com, Inc.

CIIX’s goal is to become the primary Chinese publicly traded company offering real-time financial information on its website. It conducts research & development on cannabidiol, as well as providing global retail distribution to the Chinese-speaking community. It has an online store based in the free trade zone of Shanghai, China, and plans to open a brick-and-mortar unit in San Gabriel, California. It markets hemp-based, legalized cannabidiol and other health products as well as planning the debut of a subscription website which will have the latest news on cryptocurrencies, such as bitcoin.

CIIX’s year-over-year operating revenues grew by 76% in FY2017. The consumer market for hemp-derived cannabidiol products is projected to grow at a 55% compound annual growth rate (CAGR) from $170 million in 2016 to $1 billion within three years (http://nnw.fm/oApL5). Consilium Global Research projects that CIIX sales will reach $14.8 million by FY2020, skyrocketing at a CAGR of nearly 100% (http://nnw.fm/73IRz). It also projects that the global CBD industry will reach $2.1 billion in consumer sales by 2020, propelled by a CAGR of about 80%.

“We are incredibly fortunate that Paul has agreed to return as our Chief Financial Officer,” Warren Wang, founder and CEO of CIIX, stated in a news release. “We look forward to his contributions in the financial and contractual management of the Company’s growth. Moreover, Paul shares our passion for excellence, innovation and entrepreneurial thinking. I am confident that Paul will serve effectively as our CFO just as he did in the past, helping us to build an infrastructure that supports long-term growth.”

For more information, visit the company’s website at www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Mon Oct 02, 2017 4:10 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Names Fannie Tang as Marketing Director of CBD Biotechnology Co., Ltd.

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has appointed skin care industry veteran and Shanghai beauty influencer Fannie (Chun Fang) Tang as marketing director of its wholly-owned CBD Biotechnology Co., Ltd. enterprise, effective immediately. Tang will be responsible for developing and implementing branding strategies for the company’s CBD Magic Hemp Series skin care line in China. “With over twenty years of marketing and branding experience in the skin care and cosmetics industry, I believe CBD Biotechnology is extremely fortunate to be working with Ms. Tang,” Summer Yun, CEO of CBD Biotechnology, stated in the news release. “Ms. Tang’s concept of ‘Beauty Derives from Nature and Creation’ aligns with CBD Biotechnology’s vision to develop an innovative, natural skin care band. Moreover, Ms. Tang has proven success in the industry in this region. Through her efforts, we are confident that CBD Biotechnology will position itself to become a leader in China’s skin care industry.” Tang brings more than two decades of industry experience to the CBD Biotechnology team, having previously served as the CEO of L.D. Waxson, a leading skin care company with a footprint throughout China and much of Southeast Asia.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Tue Oct 10, 2017 5:26 pm

NetworkNewsBreaks – SeeThruEquity Issues Update on ChineseInvestors.com, Inc. (CIIX)

SeeThruEquity has updated its coverage and maintained its price target of $3.75 on shares of ChineseInvestors.com, Inc.’s (OTCQB: CIIX) stock. Among other highlights, the analyst noted the company’s recently released financial results for the full year fiscal 2017. The company reported revenue growth of 75.9% over 2016, with revenues dramatically increasing in both its investor relations and subscription services segments. The analyst also noted the company’s firm focus on the emerging cannabidiol (CBD) health products market. CIIX has high expectations for its wholly owned foreign subsidiary CBD Biotechnology Co. Ltd.’s new “CBD Magic Hemp” skin care line. CBD Biotechnology recently completed the record filing process with the China Food & Drug Administration for its first line of hemp-infused skin care products.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Wed Oct 11, 2017 6:14 pm

ChineseInvestors.com, Inc. (CIIX) Markets Hemp-Infused CBD Skin Care Line in China with Multi-Platform Strategy

- CIIX’s goal is 100% growth, cost cuts and profitability in FY2018 after recording 76% YOY operating sales jump in FY2017
- Valuation of CIIX “could explode with this huge potential market in China of 1.4 billion people,” according to investor relations director in SmallCapVoice interview
- Consilium Global Research projects CIIX sales will reach $14.8 million by FY2020

ChineseInvestors.com, Inc. (OTCQB: CIIX) is growing in numerous directions due to its diverse strategy of marketing, communications and product development both within China and to the global Chinese-speaking community. After recording YOY operating sales gains of 130% in investor relations and 57% in subscription revenue in FY2017, CEO Warren Wang said that the company’s goal is 100% more growth in FY2018 while cutting costs and achieving profitability. Overall, the company showed 76% YOY operating sales growth in FY2017. Diversity is the key to this skyrocketing growth (http://nnw.fm/B2uw1).

Through its subsidiary, CBD Biotechnology Co. Ltd., CIIX is marketing, to the 1.4 billion people of China, its CBD-infused skin care line through multiple-channels, including retail, social media and direct marketing, Alan Klitenic, director of investor relations for CIIX, told SmallCapVoice.com in an interview (http://nnw.fm/Ig7A8).

CIIX has a goal of becoming the primary Chinese publicly traded company in the medical cannabis industry. Its focus is on distributing legalized cannabidiol (CBD) to the worldwide Chinese-speaking community. Consilium Global Research projects that CIIX sales will reach $14.8 million by FY2020 (http://nnw.fm/X6ncT). The Hemp Business Journal estimates that the CBD market will reach $2.1 billion in consumer sales by FY2020, showing a compound annual growth rate (CAGR) of 80%, per Consilium Global Research.

Klitenic added that CIIX’s two divisions exhibited double- and triple-digit growth in FY2017. As it markets its line of hemp oil-infused skin care products, he said, the firm will target a large audience in China and the U.S. “We will also be selling through ecommerce on eBay and Amazon,” he said. “Our goal is to maximize revenues and shareholder value.”

He explained that by marketing the regulatory agency-approved CBD-infused skin care line in China, “Our valuation could explode with this huge potential market.” Klitenic said that the company is ready to make sales in China and spend dollars to be promotional and build its brand. Cannabis is known to have anti-inflammatory and antioxidant properties. The products have fatty acids in their hemp seed oil that improve skin complexion and maintain the skin’s moisture, according to company data.

Klitenic also noted that, this month, CIIX is planning to start broadcasting from the NYSE to its Chinese-speaking audience, offering information and video news about cryptocurrencies. “We are only an educational and news provider,” he said, aiming to answer the many questions it receives. “We recently acquired the domain name, newcoin168.com, to begin offering this video news service.”

For more information, visit the company’s website at www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Wed Oct 11, 2017 6:26 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Launches Cryptocurrency Daily Video Newscast

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced the launch of the first cryptocurrency daily video newscast in the Chinese language broadcast from the NYSE. Titled ‘Bitcoin Multimillionaire’, the video newscast aims to provide timely information and analysis regarding all aspects of the emerging digital currency world. “Many Chinese investors are seeking information and education related to the cryptocurrency sector,” Warren Wang, founder and CEO of CIIX, stated in the news release. “Similar to U.S. stocks, as the price of digital currency, such as Bitcoin, continues to increase, Chinese people all over the world are taking notice and seeking access to timely information regarding market trends, news, and analysis. We look forward to being the premier source for this information.” In addition to its ‘Bitcoin Multimillionaire’ program, CIIX plans to launch a new cryptocurrency website to serve Chinese cryptocurrency investors. The new site, which will be located at newcoin168.com, is expected to launch next month and will endeavor to “be a leader in digital media and cryptocurrency and blockchain technology education providing straightforward explanations of cryptocurrency basics, trading guidelines, real-time market commentary and analysis regarding currency mining, blockchain technology, industry hotspots, sector-related stock trends and ETFs, and other strategies and opportunities to capitalize on the bitcoin market.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Thu Oct 12, 2017 5:32 pm

ChineseInvestors.com, Inc. (CIIX) – A First Mover in CBD Skin Care

- China is the second-largest global cosmetics consumer, representing $30 billion annually
- Savvy industry veteran recruited for vast untapped CBD skin care market
- 100% of cannabis skin care product market in China up for grabs

It comes as little surprise that cannabidiol (CBD) likely possesses skin healing properties. Found in the marijuana plant, CBD is one of over 80 natural compounds in marijuana that have been used for centuries as natural medicines and therapeutics. Cannabis is a known anti-inflammatory, containing antioxidants and anti-aging elements, while hemp seed oil contains both omega-3 and omega-6 fatty acids.

In spite of vast anecdotal evidence, science has not yet definitively settled on the positive effects of CBD skin care. However, the recent article “The Role of Cannabinoids in Dermatology,” published in the prestigious Journal of American Academy of Dermatology, suggests efficacy in CBD use for the treatment of several dermatologic conditions, including pruritus, inflammatory skin disease and skin cancer (http://nnw.fm/mXI9m). It’s likely that even more beneficial effects will be found.

Further scientific validation will be icing on the cake for ChineseInvestors.com, Inc. (OTCQB: CIIX). With the introduction of its line of cannabidiol-based skin care products, CIIX is primed and fast moving into the multi-billion dollar Chinese skin care industry. The company has already filed a record of its first line of hemp-infused skin care products with the China Food and Drug Administration and expects to launch it in the next couple months. As the company stated in a recent press release, “Although ancient Chinese recognized the medicinal properties of the cannabis plant, CBD extract appears to be largely unrecognized in China today for its benefits, including but not limited to, its potential benefits to the largest visible human organ, the skin.”

China is the second-largest consumer of skin care products in the world and generates nearly $30 billion in annual retail sales. Since no other notable manufacturers have entered the cannabis skin care product market in China, CIIX would be first to market and anticipates capturing “100% of China’s market share in this novel skin care products category.” The market potential is immense.

To facilitate and expedite market dominance, CIIX recently appointed skin care industry veteran and Shanghai beauty influencer Fannie (Chun Fang) Tang as marketing director of its wholly-owned CBD Biotechnology Co., Ltd. enterprise. Well known in China, Tang will be responsible for developing and implementing branding strategies for the company’s CBD Magic Hemp Series skin care line (http://nnw.fm/TMy1e).

Tang has proven success in the industry, bringing more than two decades of industry experience and previously serving as the CEO of L.D. Waxson, a leading skin care company with a footprint throughout China and much of Southeast Asia. Moving from CEO to director of marketing is a strong testament to the opportunity. There’s little doubt that with Tang’s experience, guidance and industry connections, CBD Biotechnology will position itself to become a leader in China’s skin care industry.

For more information, visit the company’s website at www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Thu Oct 19, 2017 5:14 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Poised to be First to Market in China’s Multibillion-Dollar Skin Care Industry with Line of Cannabidiol-Based Products

ChineseInvestors.com (OTCQB: CIIX) is quickly moving into the multibillion-dollar Chinese skin care industry and is introducing its first line of cannabidiol (CBD) based skin care products. CIIX has already filed a record with the China Food and Drug Administration for this line of hemp-infused skin care products and hopes to launch within the next couple of months. An article discussing this reads: “China is the second-largest consumer of skin care products in the world and generates nearly $30 billion in annual retail sales. Since no other notable manufacturers have entered the cannabis skin care product market in China, CIIX would be first to market and anticipates capturing ‘100% of China’s market share in this novel skin care products category.’ The market potential is immense. To facilitate and expedite market dominance, CIIX recently appointed skin care industry veteran and Shanghai beauty influencer Fannie (Chun Fang) Tang as marketing director of its wholly-owned CBD Biotechnology Co., Ltd. enterprise. Well known in China, Tang will be responsible for developing and implementing branding strategies for the company’s CBD Magic Hemp Series skin care line (http://nnw.fm/TMy1e).”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Fri Oct 20, 2017 3:57 pm

ChineseInvestors.com, Inc. (CIIX) On Target for Impressive Gains in CBD Healthcare Markets

- CIIX reported nearly 76 percent revenue growth for full year fiscal 2017
- Price target of $3.75 reflects investment potential of cannabis initiatives
- Recent launch of cryptocurrency daily Chinese video newscast from NYSE first of its kind
- CBD industry is expected to grow to $2.1 million in consumer sales by 2020 with $450 million coming from hemp-based sources

ChineseInvestors.com, Inc. (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States, China and Canada, continues to innovate and create exceptional value opportunities with the launch of a CBD skincare line in China and a cryptocurrency daily Chinese video newscast from the NYSE. Notably, SeeThruEquity has updated and maintained its target price of $3.75 on shares of ChineseInvestors.com, Inc.’s stock.

Among the reported highlights is the company’s revenue growth of 75.9% over 2016, with revenues dramatically increasing in both its investor relations and subscription services segments (http://nnw.fm/nG6pX). CIIX’s business strategy of targeting the emerging cannabidiol (CBD) health products market includes bringing a new website online for its subsidiary ChineseCBDoil.com (http://nnw.fm/asKI9). This website offers the world’s first “CBD health products online store in the Chinese language.” At the same time, CIIX launched a Chinese language Yelp-style mobile application that contains a location-enabled database of recreational and medical marijuana dispensaries, as well as a platform to review and discuss various cannabis and CBD products.

The company’s wholly owned foreign subsidiary CBD Biotechnology recently completed the record filing process with the China Food & Drug Administration for its first retail line of hemp-infused skin care products. With this essential regulatory milestone met and several products designed and manufactured, ChineseInvestors.com is ready to promote and sell its CBD Hemp Oil and CBD infused skin care products in China, Alan Klitenic, CIIX director of investor relations said in a SmallCapVoice interview (http://nnw.fm/5V7jK).

Adding to the company’s robust growth pattern, the launch this week of the first cryptocurrency daily video newscast in the Chinese language from the NYSE is generating attention. Titled “Bitcoin Multimillionaire,” the video newscast aims to provide information and analysis regarding all aspects of the emerging digital currency world.

“Many Chinese investors are seeking information and education related to the cryptocurrency sector,” said Warren Wang, founder and CEO of CIIX said in a news release (http://nnw.fm/hHh0t). “Similar to U.S. stocks, as the price of digital currency, such as Bitcoin, continues to increase, Chinese people all over the world are taking notice and seeking access to timely information regarding market trends, news and analysis. We look forward to being the premier source for this information.”

Investors should also watch for CIXX to launch a website to serve the Chinese cryptocurrency investor. The new site, located at newcoin168.com, will seek to “be a leader in digital media and cryptocurrency and blockchain technology education,” providing straight forward explanations on all aspects of the cryptocurrency market while providing strategies and other opportunities to capitalize on this fast-paced financial industry.

For more information, visit the company’s website at www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Wed Oct 25, 2017 5:59 pm

NetworkNewsBreaks – ChineseInvestors.com (CIIX) Targets CBD Health Products Market through New Website, Mobile App

ChineseInvestors.com (OTCQB: CIIX) continues to rapidly grow in 2017, which is primarily attributed to the company’s focus on the cannabidiol (CBD) health products market. An article discussing this reads: “Among the reported highlights is the company’s revenue growth of 75.9% over 2016, with revenues dramatically increasing in both its investor relations and subscription services segments (http://nnw.fm/nG6pX). CIIX’s business strategy of targeting the emerging cannabidiol (CBD) health products market includes bringing a new website online for its subsidiary ChineseCBDoil.com (http://nnw.fm/asKI9). This website offers the world’s first ‘CBD health products online store in the Chinese language.’ At the same time, CIIX launched a Chinese language Yelp-style mobile application that contains a location-enabled database of recreational and medical marijuana dispensaries, as well as a platform to review and discuss various cannabis and CBD products.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Thu Oct 26, 2017 5:41 pm

ChineseInvestors.com, Inc. (CIIX) Launches New Daily Video Broadcast “Bitcoin Multimillionaire” By Teaming With Wall Street Multimedia, Inc.

- Wall Street Multimedia telecasts reach 125 million households in China, targeting the Chinese-speaking global market, raising CIIX’s profile in cryptocurrency worldwide
- CIIX expands consulting services, focuses on advertising, subscription revenues, and sales of hemp oil (CBD) related products
- CIIX reported 76% YOY operating sales growth in FY2017, projected by Consilium Global Research to reach $14.8 million by FY2020

ChineseInvestors.com, Inc. (OTCQB: CIIX) has launched its daily video telecast on cryptocurrencies from the NYSE, “Bitcoin Multimillionaire,” by teaming with specialist broadcaster to the Chinese-speaking global community, Wall Street Multimedia, Inc. (WSM) (http://nnw.fm/NElH4).

CIIX’s goal is to become the primary Chinese publicly traded company that offers real time information on its website. In addition to its “Bitcoin Multimillionaire” broadcasts, it offers consulting services, subscriptions and retails hemp oil-based cannabidiol (CBD) products under the “OptHemp” brand and plans to market a line of hemp-infused skin care products through its wholly-owned subsidiary, CBD Biotechnology Co. Ltd.

In a 10Q filing (http://nnw.fm/OH4y5), CIIX said it was working with WSM to reach the Chinese-speaking community throughout the world to offer more information and news about cryptocurrency. “In an effort to expand its media products, as the first year of fiscal year 2018 came to a close, the company announced that it would be working with Wall Street Multimedia, an independent news agency located in the NYSE, to produce a daily cryptocurrency video newscast in Chinese, providing timely information and exclusive analysis regarding all aspects of the emerging digital currency world, including specific cryptocurrencies, such as Bitcoin and Ethereum, industry trends, price movement, blockchain technology, sector-related stocks and ETF’s, etc.”

Consilium Global Research has projected that CIIX will reach revenues of $14.8 million by FY2020, representing a nearly 100% compound annual growth rate (CAGR) from FY2016-FY2020 (http://nnw.fm/BAtB6). To boost its revenues, the company is expanding its consulting services, targeting advertising and subscriptions, as well as sales of its hemp-oil CBD products.

For more information, visit the company’s website at www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

PreviousNext

Return to QualityStocks Featured Companies

Who is online

Users browsing this forum: No registered users and 1 guest

cron